People: Vitrolife AB (VITRO.BE)
26 May 2017
Mr. Thomas Axelsson has served as Chief Executive Officer (CEO) of Vitrolife AB since November 17, 2011. He was, among other things, CEO of Stille and Artema. Currently, he is Member of the Board of Directors at MedCap AB. He has also been Chairman of the Board of Directors at SBL Vaccin AB, Neoventa Medical AB, Dipylon Medical AB (previously CMA Microdialysis AB) and Airsonett AB, among others. He was also Business Area Manager at Baxter. He holds a Master of Science degree.
|Total Annual Compensation, SEK||4,496,000|
|Restricted Stock Awards, SEK||--|
|Long-Term Incentive Plans, SEK||--|
|All Other, SEK||--|
|Fiscal Year Total, SEK||4,496,000|